GCP
RXDX

GSA Capital Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

GSA Capital Partners’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,345
Closed -$368K – 2053
2022
Q4 		$368K Sell
3,345
-4,420
-57% -$486K 0.05% 803
2022
Q3 		$458K Buy
+7,765
New +$458K 0.06% 638